A‐80426, a potent α2‐adrenoceptor antagonist with serotonin uptake blocking activity and putative antidepressant‐like effects: I. Biochemical profile
Authors:
- 1 August 1995
- journal article
- Published by Wiley in Drug Development Research
- Vol. 35 (4) , 237-245
Abstract
A‐80426 (N‐[2‐(benzofuran‐6‐yl)ethyl]‐N‐[(R)−( + )‐5‐methoxy‐1,2,3,4‐tetrahydronaphthalen‐1‐yl methyl]‐N‐methylamine) is a novel compound with potential antidepressant activity. A‐80426 inhibits synaptosomal serotonin (5HT) uptake (IC50 = 13 nM) more potently than fluoxetine (IC50 = 308 nM), and blocks [3H]‐paroxetine binding (K1 = 3.8 nM) to 5HT uptake sites. A‐80426 inhibits [3H]‐rauwolscine binding to α2‐adrenoceptors (K1 = 2.0 nM), blocks α2‐adrenoceptors (pEC30 = 7.4–7.5) in electrically stimulated rat atria and vas deferens, and increases electrically stimulated [3H]‐NE overflow from brain slices. A‐80426 lacks significant activity at isolated tissue models of α1‐ or β‐adrenergic sites or at M3 muscarinic or H1 histaminergic receptors. A‐80426 has negligible radioligand binding activity at 5HT1 and β‐adrenergic receptors, but exhibits a K1 value of 144 nM at 5HT2 receptors. A‐80426 interacts with both dopamine D1 (K1 = 744 nM) and D2 (K1 = 51.5 nM) receptors. Functionally, the compound antagonizes dopamine‐induced changes in cyclic AMP formation with K1 values of 133 nM and 185 nM at D1 and D2 receptors, respectively. The potent α2‐adrenoceptor blocking activity of A‐80426 in radioligand binding assays is not reflected in isolated tissue bioassays, and may thus have less functional consequence in determining the in vivo profile of the compound. Accompanying behavioral data [Giardina et al., 1995], while indicating activity in the olfactory bulbectomized rat model of antidepressant action, shows a marked reduction in the α2‐antagonistic properties of A‐80426 in other in vivo models, suggesting that the antidepressant‐like activity may be caused primarily by inhibition of 5HT uptake.Keywords
This publication has 31 references indexed in Scilit:
- A‐80426, a potent and selective α2‐adrenoceptor antagonist with serotonin uptake‐blocking activity and putative antidepressant‐like effects: II. Pharmacology profileDrug Development Research, 1995
- A‐75169 HCI: Pharmacological profile and ocular pharmacology studies of a new α‐2 antagonistDrug Development Research, 1993
- Molecular Design of Novel Ligands for 5-HT1AReceptorsJournal of Receptor Research, 1991
- Modulation of 5-hydroxytryptamine release by presynaptic inhibitory ?2-adrenoceptors in the human cerebral cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 1990
- Functional evidence for heterogeneity of peripheral prejunctional α2‐adrenoceptorsBritish Journal of Pharmacology, 1990
- ?2-Adrenoceptor mediated inhibition of the release of radiolabelled 5-hydroxytryptamine and noradrenaline from slices of the dorsal region of the rat brainNaunyn-Schmiedeberg's Archives of Pharmacology, 1988
- Autoreceptors and ?2-adrenoceptors at the serotonergic axons of rabbit brain cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 1986
- PRE‐ AND POSTJUNCTIONAL EFFECTS OF CLONIDINE‐ AND OXYMETAZOLINE‐LIKE COMPOUNDS IN GUINEA‐PIG ILEAL PREPARATIONSBritish Journal of Pharmacology, 1981
- Histamine receptors in the guinea pig ileumNaunyn-Schmiedeberg's Archives of Pharmacology, 1979
- Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary arteryNaunyn-Schmiedeberg's Archives of Pharmacology, 1977